Dr. Chetna Deep Lamba

@ccrhindia.nic.in

Research Officer(H)/Scientist-3
Central council for Research in Homoeopathy

Dr. Chetna Deep Lamba

EDUCATION

BHMS, MD, PhD

RESEARCH, TEACHING, or OTHER INTERESTS

Complementary and alternative medicine
13

Scopus Publications

541

Scholar Citations

9

Scholar h-index

8

Scholar i10-index

Scopus Publications

  • How to Assess Variation in Homeopathic Prognostic Factor Research?
    Lex Rutten, José E. Eizayaga, Harleen Kaur, Shalini Rao, Anurag Bajpai, Chetna Deep Lamba, Jyoti Sachdeva, Vinitha E. R., Sonia Raizada, Rompicherla Gr. Kiranmayee, Bondarkar Rajashekhar, Chittranjan Kundu, Vaishali Shinde, Sujata Choudhury, Amulya Ratan Sahoo, Ratan Chandra Shil, Abhijit Chakma, Nidhi Mahajan, Alok Mishra, Anil Khurana, Praveen Oberai, Raj K. Manchanda
    Homeopathy, 2026
    We need to classify the outcome of prognostic factor research (PFR), especially regarding polar symptoms (PS) — symptoms with opposite values such as amelioration/desire and aggravation/aversion. For instance, in a data collection project 22.9% of the patients responding well to Arsenicum album (Ars) had ‘Desire salt’ and 5.7% ‘Aversion salt’. Can such differences be explained by statistical variation?Frequency distributions of PS were analysed and compared with previous research to reveal differences. Cumulative binomial probability (CBP) and 95% confidence intervals (95% CIs) were calculated to assess the influence of statistical variation on the difference between the medicine population and the remainder of the population and the difference between opposite poles. CBP and 95% CI were compared regarding usefulness for daily practice. 95% CIs were used to calibrate the CBP. Corroboration by comparable symptoms was also used to validate outcomes.In several PS, there was asymmetry between opposite poles and a difference compared with previous research. The most probable cause was using questionnaires, disregarding clinical expertise. This results in asymmetrical frequency distributions when symptoms are common and the criterion ‘more than average’ was ignored. This, in turn, results in relatively low likelihood ratios (LRs) caused by a ‘ceiling effect’.The CBP correlates with 95% CI, indicates the amount of overlap of 95% CIs, and is useful to classify the statistical certainty of PFR outcome. Based on CBP and difference of CBP for opposite symptoms, LR outcome was classified as statistically ‘Certain’, ‘Probable’, ‘Possible’ or ‘Questionable’. Cut-offs between classes were based on expert estimates. Part of the outcome could be corroborated by the outcome of similar or opposite symptoms.Asymmetry of symptom frequency distributions in PS can be caused by practitioners not using their expert knowledge while assessing symptoms. A classification of reliability of data based on cumulative binomial chance is more informative and is better understood by experts in homeopathy. Nevertheless, classification of reliability remains partly subjective. Corroboration of outcome and clinical judgment are indispensable for estimating clinical validity of PFR outcomes. Practitioners and researchers participating in PFR need training in statistics and homeopathy respectively.
  • MONARCH Inventory for Causal Attribution in Homeopathy Case Reports: Explanation and Elaboration
    Chetna Deep Lamba, Nidhi Mahajan, Vishwa Kumar Gupta, Lex Rutten, Michael Teut, Lefteris Tapakis, Todd Hoover, Anna Gerstenhoefer, Yuen Ying Yvonne Fok, Rajkumar Manchanda, Robbert van Haselen
    Homeopathy, 2025
    Background The Modified Naranjo Criteria for Homeopathy (MONARCH) inventory is a novel and useful tool for assessing the likelihood of a causal relationship between the homeopathic intervention and the ultimate clinical outcome. Objectives To explain and elaborate on the use of the MONARCH inventory to improve its consistency of use and thereby elevate the overall quality and evidentiary value of homeopathy case reports. Explanation and Elaboration Each of the 10 MONARCH inventory domains is explained and elaborated with the aid of references from published literature and hypothetical clinical situations. The MONARCH total score can range from −6 to +13; within that range, an arithmetic total of +6 is available from the scores of four critical domains, which should be given prominence in the overall consideration of causality. In reporting a clinical case, great importance should be placed on the narrative of the MONARCH evaluation process, domain by domain. Conclusion The application of MONARCH allows us to evaluate the likelihood of a causal relationship between the intervention and the observed clinical outcomes in successfully treated cases, thereby augmenting their evidentiary value.
  • Enhancing Homeopathic Prescribing for Chronic Cough by Classifying the Reliability of Polar Symptoms
    Harleen Kaur, Lex Rutten, José E. Eizayaga, Shalini Rao, Anurag Bajpai, Chetna Deep Lamba, Jyoti Sachdeva, Vinitha ER, Sonia Raizada, Rompicherla G.R. Kiranmayee, Bodankar Rajashekhar, Chittaranjan Kundu, Vaishali Shinde, Sujata Choudhury, Amulya Ratna Sahoo, Ratan Chandra Shil, Abhijit Chakma, Nidhi Mahajan, Alok Mishra, Anil Khurana, Praveen Oberai, Raj K. Manchanda
    Homeopathy, 2025
    Assessment of relationship between polar symptoms (PS), such as weather, activity or food, and homeopathic medicines in chronic cough has produced some confusing outcomes. Statistical variation in the data partly explains the seemingly conflicting outcomes in prognostic factor research (PFR) of PS. Classification of statistical probability and selection of statistically reliable data can reduce conflicting outcomes. To make an inventory of statistically reliable PS and their relationship with homeopathic medicines in chronic cough. A prospective observational cohort study was conducted at 10 outpatient centers of the Central Council for Research in Homoeopathy, India. Patients with chronic cough were followed for 12 months. Effect of treatment was assessed using the ORIDL (Outcome in Relation to Impact on Daily Living) instrument, with symptom severity and health status evaluated respectively via the Cough Severity Index and EuroQoL 5D-5L. Prevalence and likelihood ratios (LRs) of PS were calculated for general and medicine-specific populations. Cumulative binomial probability (CBP) was used to determine whether symptom prevalence among good responders to specific medicines significantly differed from that of the general population. Some LRs were unexpectedly low, which could be explained by asymmetry of frequency distributions, resulting in high prevalence of one symptom pole. CBP for homeopathic medicines was subsequently performed, with 131 symptoms classified as ‘certain’ or ‘probable’: 21 symptoms for Arsenicum album, 23 for Bryonia, 11 for Calcarea carbonica, 3 for Lycopodium, 15 for Natrium muriaticum, 5 for Nux vomica, 17 for Phosphorus, 13 for Pulsatilla, 10 for Silicea, and 13 for Sulphur. Conflicting outcomes in PFR of PS can partly be explained by statistical variation. A classification of reliability was not feasible when expressed using the classical 95% confidence interval but could be achieved by CBP, resulting in certain and probable PS for 10 medicines. We still need clinical expertise and corroboration for future research. Practitioners need scientific training to prevent bias and use research instruments such as Likert scales and questionnaires.
  • Homoeopathic treatment for chronic cough – a multicentric, prospective, observational cohort study
    Harleen Kaur, Lex Rutten, Chetna Deep Lamba, Shalini Rao, Anurag Bajpai, Jyoti Sachdeva, Sonia Raizada, Sujata Choudhury, Vaishali Shinde, Vinitha ER, Chittarajan Kundu, Partha Pratim Pal, Rompicherla GR Kiranmayee, Amulya Ratna Sahoo, Bodankar Rajashekhar, Ratan Chandra Shil, Nidhi Mahajan, Anil Khurana, Praveen Oberai, Raj K. Manchanda
    International Journal of High Dilution Research, 2024
    ContextCough is a major symptom of respiratory and some non-respiratory ailments for which patients usually seek primary medical care. Homoeopathy is frequently used for treatment of chronic cough.ObjectiveThis study aims to assess whether homoeopathy is useful for treating chronic cough resulting from Upper airway cough syndrome (UACS), Asthma and related syndromes, or Gastroesophageal reflux disease (GERD).Study Design A multi‑centre, exploratory, prospective trial.Study settingThe study was conducted in the outpatient departments of 10 centres of CCRH, India from May 2018 – June 2020.PatientsPatients of any gender, between 7-65 years of age, presenting with cough lasting >8 weeks, were enrolled.Main Outcome Measure(s)Cough Severity Index (CSI) and EQ-5D-5L scales were used to analyse the outcomes.ResultsOut of 2397 patients screened only 706 cases, with minimum four follow ups were analysed, on modified Intention to Treat (mITT) basis. CSI and EQ-5D-5L scores were used to analyse the outcomes of the study. The mean of the CSI score at baseline was 19.09 whereas it reduced to 3.89 in the eighth follow-up with p value <0.01. The mean of the EQ-5D-5L score at baseline was 50.59 which increased to 73.79 in the last follow-up, with p-value<0.05. Phosphorus, Arsenic album, Pulsatilla, Sulphur, Lycopodium and Silica were found to be the most frequently prescribed medicines.
  • Case Reporting in Homeopathy-An Overview of Guidelines and Scientific Tools
    Michael Teut, Robbert A. van Haselen, Lex Rutten, Chetna Deep Lamba, Gerhard Bleul, Susanne Ulbrich-Zürni
    Homeopathy, 2022
    Case reports have been of central importance to the development of homeopathy over the past 200 years. With a special focus on homeopathy, we give an overview on guidelines and tools that may help to improve the quality of case reports. Reporting guidelines such as CARE (Case Report), HOM-CASE (Homeopathic Clinical Case Reports), and the WissHom Documentation Standard help to improve the quality of reporting and strengthen the scientific value of a case report. Additional scientific tools such as prospective outcome assessment, prognostic factor research, cognition-based medicine, and the Modified Naranjo Criteria for Homeopathy (MONARCH) score may be helpful in improving case documentation and evaluation.
  • Counting Polar Symptoms: How to Represent Results?
    Lex Rutten, José Eizayaga, Harleen Kaur, Chetna Deep Lamba, Jyoti Sachdeva, Anil Khurana, Praveen Oberai, Rajkumar Manchanda, Sonia Raizada, Sujata Chaudhary, Vaishali Shinde, Vinitha Edavattath Ramanan, Chittaranjan Kundu, Pratha Pratim Pal, Rompicherla GR Kiranmayee, Amulya Ratan Sahoo, Bodankar Rajeshekhar, Ratan Chandra Shil, Nidhi Mahajan
    Homeopathy, 2021
    Background Polar symptoms (PS)—symptoms with opposite values—are frequently used in homeopathy, but have many misleading entries in the repertory. This is caused by using absolute occurrence of symptoms, causing the same medicine to appear in both (opposite) symptom rubrics, and by lack of comparison with other medicines. Some PS, like ‘aversion/desire for sweets’ have a frequency distribution that is not evenly distributed around the neutral value: a desire for sweets is much more common than aversion. A desire for sweets is an indication for a specific medicine only if this desire occurs more frequently in this specific medicine population than in the remainder of the population. We need to find the best way to represent this difference. Methods A multi-centre, explorative, prospective, observational study was conducted by nine centres of the Central Council for Research in Homoeopathy. Two-hundred and sixteen patients were enrolled with chronic cough lasting more than 8 weeks, and received usual homeopathic care. During intake, 30 general PS, 27 polar cough symptoms and 3 non-polar cough symptoms were checked. Different ways of representing results were explored, including two quantities borrowed from mechanics: Centre of Mass (CoM) and Leverage. Results At the fourth follow-up, three medicines with more than 10 cases with good results were identified: 20 Phosphorus, 19 Pulsatilla and 13 Sulphur. The mean value of the frequency distribution of some symptoms in the whole sample was considerably different from the neutral value. Comparing a medicine population with the remainder of the respective population can give results that differ from polarity analysis. For some symptoms, the ‘distance’ (Leverage) between the CoMs of the medicine population and the remainder of the population was clearer than the likelihood ratio (LR). Conclusion If the LR value is not clear about the prognostic value in PS, notions from mechanics such as CoM and Leverage can clarify how to interpret a polar symptom.
  • Erratum: Evaluation of the Modified Naranjo Criteria for Assessing Causal Attribution of Clinical Outcome to Homeopathic Intervention as Presented in Case Reports (Homeopathy (2020) 109 (e1-e2) DOI: 10.1055/s-0040-1701251)
    Chetna Deep Lamba, Vishwa Kumar Gupta, Robbert van Haselen, Lex Rutten, Nidhi Mahajan, Abdul Motin Molla, Richa Singhal
    Homeopathy, 2020
    Correction to: Evaluation of the Modified Naranjo Criteria for Assessing Causal Attribution of Clinical Outcome to Homeopathic Intervention as Presented in Case ReportsHomeopathy 2020; 109(04): 191-197DOI: 10.1055/s-0040-1701251
  • Evaluation of the Modified Naranjo Criteria for Assessing Causal Attribution of Clinical Outcome to Homeopathic Intervention as Presented in Case Reports
    Chetna Deep Lamba, Vishwa Kumar Gupta, Robbert van Haselen, Lex Rutten, Nidhi Mahajan, Abdul Motin Molla, Richa Singhal
    Homeopathy, 2020
    Objectives The objective of this study was to establish the reliability and content validity of the “Modified Naranjo Criteria for Homeopathy—Causal Attribution Inventory” as a tool for attributing a causal relationship between the homeopathic intervention and outcome in clinical case reports. Methods Purposive sampling was adopted for the selection of information-rich case reports using pre-defined criteria. Eligible case reports had to fulfil a minimum of nine items of the CARE Clinical Case Reporting Guideline checklist and a minimum of three of the homeopathic HOM-CASE CARE extension items. The Modified Naranjo Criteria for Homeopathy Inventory consists of 10 domains. Inter-rater agreement in the scoring of these domains was determined by calculating the percentage agreement and kappa (κ) values. A κ greater than 0.4, indicating fair agreement between raters, in conjunction with the absence of concerns regarding the face validity, was taken to indicate the validity of a given domain. Each domain was assessed by four raters for the selected case reports. Results Sixty case reports met the inclusion criteria. Inter-rater agreement/concordance per domain was “perfect” for domains 1 (100%, κ = 1.00) and 2 (100%, κ = 1.00); “almost perfect” for domain 8 (97.5%, κ = 0.86); “substantial” for domains 3 (96.7%, κ = 0.80) and 5 (91.1%, κ = 0.70); “moderate” for domains 4 (83.3%, κ = 0.60), 7 (67.8%, κ = 0.46) and 9 (99.2%, κ = 0.50); and “fair” for domain 10 (56.1%, κ = 0.38). For domains 6A (46.7%, κ = 0.03) and 6B (50.3%, κ = 0.18), there was “slight agreement” only. Thus, the validity of the Modified Naranjo Criteria for Homeopathy tool was established for each of its domains, except for the two that pertain to direction of cure (domains 6A and 6B). Conclusion The Modified Naranjo Criteria for Homeopathy—Causal Attribution Inventory was identified as a valid tool for assessing the likelihood of a causal relationship between a homeopathic intervention and clinical outcome. Improved wordings for several criteria have been proposed for the assessment tool, under the new acronym “MONARCH”. Further assessment of two MONARCH domains is required.
  • Calendula mother tincture vs normal saline for ulcer dressing as an add-on to Individualized Homoeopathic Intervention in the management of Diabetic Foot Ulcer: A Randomized Controlled Pilot Study
    HimaBindu Ponnam, ChetnaDeep Lamba, Praveen Oberai, SyedViquar Masood, Suryanarayana Yandamuri, MNarsing Rao, RajKumar Manchanda
    Indian Journal of Research in Homoeopathy, 2020
    Background: Despite standard management, healing rate of Diabetic Foot Ulcers (DFUs) remains low, posing risk of lower extremity amputation. Objectives: This study was undertaken to evaluate if Calendula Q has added benefit over individualized homoeopathic intervention (IHI). The primary objective was to achieve complete epithelialisation within 20 weeks and secondary objective was to assess the changes in quality of life using DFU Scale-short form (DFU-SF) questionnaire. Materials and Methods: A randomised controlled pilot study with a 20-week intervention was conducted from 2014-2017. 277 cases were screened and 60 cases were enrolled and randomised to Group I: IHI + Calendula Q dressing (n= 30) and Group II: IHI + normal saline (NS) dressing (n = 30), along with standard conventional medication for glycaemic control. Results: The mean time (Group I= 12 weeks, Group II= 11 weeks) of ulcer healing in both groups showed no statistically significant difference, thus calendula Q used for dressing did not have any added benefits (p= 0.0521). Arsenicum album (n= 14, 23.3%), Lycopodium (n= 8, 13.3%), Silicea (n= 7, 11.7%), Sulphur (n= 6, 10%), Phosphorus (n= 5, 10%) and Sepia (n=5, 10%) were found to be effective medicines. Conclusion: IHI, along with wound hygiene and conventional diabetic management, proved to be effective, irrespective of whether Calendula Q or normal saline was used for wound hygiene, thus leading to early, complete epithelialisation of Wagner's first and second stages of DFUs. Further studies comparing IHI with standard care are warranted.
  • Homoeopathic therapy in cervical spondylosis pain management: A randomised, double-blind, placebo-controlled trial
    Jaya Gupta, Ramesh Bawaskar, Prakash Rao, Ashish Shivadikar, Paul Sumithran, Ramendra Pal, Shahid Ali, Hima Bindu, MD Arya, ChetnaDeep Lamba, Arvind Kumar, Dimpi Kulshreshtha
    Indian Journal of Research in Homoeopathy, 2020
    Background: Homoeopathic medicines are known to be effective in alleviating pain and other troublesome symptoms of patients suffering from cervical spondylosis. Objective: The primary objective was to evaluate the effectiveness of predefined homoeopathic medicines in the pain management of cervical spondylosis using the Cervical Spondylosis Pain Management Scale (CSPMS). Methods: A prospective, double-blind randomised placebo-controlled multicentric clinical trial was conducted from April 2012 to May 2013. Results: Sixty-seven cases were enrolled in the Homoeopathy group and 69 in the placebo group. One hundred and thirty-four cases that completed the follow-ups were analysed. The improvement in pain was 56.18% in the Homoeopathy group and 46.45% in the placebo group, as per CSPMS. The mean improvement between the groups was not significant: 60.36% in the Homoeopathy group and 48.66% in the placebo group. The mean score of quality of life, assessed using the 'Patient's Global Impression of Change Scale,' was 2.29 ± 1.90 quality of life in the Homoeopathy group and 2.93 ± 2.28 in the placebo group. There was 27.95% more improvement in the Homoeopathy group, as compared to the placebo group. Among the most used medicines were Rhus toxicodendron (n = 19) 28.8%, Calcarea carbonica (n = 7) 10.6%, Kalmia latifolia (n = 7) 10.6% and Paris quadrifolia (n = 8) 12.1%. Conclusion: Homoeopathic medicines are effective in management of acute pain due to cervical spondylosis.
  • Optimising the use of polar symptoms in Homoeopathy: Introduction to a pilot study of prognostic factor research in chronic cough
    Harleen Kaur, ChetnaDeep Lamba, Jyoti Sachdeva, Lex Rutten, Anil Khurana, Praveen Oberai, RajKumar Manchanda, Sonia Raizada, Sujata Chaudhury, VinithaEdavattath Ramanan, Vaishali Shinde, Chittaranjan Kundu, ParthaPratim Pal, RompicherlaGr Kiranmayee, AmulyaRatna Sahoo, Bodankar Rajeshekhar, RatanChandra Shil, Nidhi Mahajan
    Indian Journal of Research in Homoeopathy, 2020
  • Homoeopathic medicine - Sepia for the management of menopausal symptoms: A multicentric, randomised, double-blind placebo-controlled clinical trial
    Jaya Gupta, Dimpi Kulshreshtha, ChetnaDeep Lamba, Payal Gupta, Vaishali Shinde, Bharti Wadhwa, Arti Soren, JS Arya, Munmun Koley, Abhishek Pramanik, Suraia Parveen, Arvind Kumar
    Indian Journal of Research in Homoeopathy, 2019
  • Management of distress during climacteric years by homeopathic therapy
    Chaturbhuja Nayak, Vikram Singh, Krishna Singh, Hari Singh, Jaya Gupta, Chetna Deep Lamba, Anita Sharma, Bindu Sharma, Balachandran Indira, Subburayalu Bhuvaneshwari, Simran Kaur Bindra, Kunapuli Sree Venkata Bharata Luxmi
    Journal of Alternative and Complementary Medicine, 2011

RECENT SCHOLAR PUBLICATIONS

  • How to assess variation in homeopathic prognostic factor research?
    L Rutten, JE Eizayaga, H Kaur, S Rao, A Bajpai, CD Lamba, J Sachdeva, ...
    Homeopathy 115 (01), 033-045 , 2026
    2026
    Citations: 7
  • Enhancing Homeopathic Prescribing for Chronic Cough by Classifying the Reliability of Polar Symptoms
    H Kaur, L Rutten, JE Eizayaga, S Rao, A Bajpai, CD Lamba, J Sachdeva, ...
    Homeopathy , 2025
    2025
    Citations: 2
  • MONARCH inventory for causal attribution in homeopathy case reports: Explanation and elaboration
    CD Lamba, N Mahajan, VK Gupta, L Rutten, M Teut, L Tapakis, T Hoover, ...
    Homeopathy 114 (03), 173-182 , 2025
    2025
    Citations: 7
  • Homoeopathic treatment for chronic cough–a multicentric, prospective, exploratory trial
    H Kaur, L Rutten, S Rao, A Bajpai, CD Lamba, J Sachdeva, V ER, ...
    International Journal of High Dilution Research-ISSN 1982-6206 23 (cf), 146-160 , 2024
    2024
    Citations: 3
  • A Multi-Centric Single-Blind Randomized Placebo-Controlled Trial to Evaluate the Efficacy of the Individualized Homeopathic Intervention in Breast Fibroadenoma
    CD Lamba, P Oberai, B Wadhwa, S Parveen, A Soren, R Bhuvaneswari, ...
    OBM Integrative and Complementary Medicine 8 (2), 1-20 , 2023
    2023
    Citations: 1
  • Case reporting in homeopathy—an overview of guidelines and scientific tools
    M Teut, RA van Haselen, L Rutten, CD Lamba, G Bleul, S Ulbrich-Zürni
    Homeopathy 111 (01), 002-009 , 2022
    2022
    Citations: 40
  • An analytical study to establish the role of Calendula Q as a topical wound dressing in partial-thickness burn wound
    HK Sharma, D Dev, CD Lamba, PK Thayal, A Mohan
    Indian Journal of Burns 30 (1), 33-38 , 2022
    2022
  • Obituary: Prof. Emeritus Dr. Girendra Pal
    S Kaushik, P Oberai, N Mahajan, CD Lamba
    Indian Journal of Research in Homoeopathy 16 (3), 8 , 2022
    2022
  • Counting polar symptoms: how to represent results?
    L Rutten, J Eizayaga, H Kaur, CD Lamba, J Sachdeva, A Khurana, ...
    Homeopathy 110 (01), 027-035 , 2021
    2021
    Citations: 4
  • Erratum: Evaluation of the Modified Naranjo criteria for assessing causal attribution of clinical outcome to homeopathic intervention as presented in case reports
    CD Lamba, VK Gupta, R van Haselen, L Rutten, N Mahajan, AM Molla, ...
    Homeopathy 109 (04), e1-e2 , 2020
    2020
    Citations: 4
  • Evaluation of the modified Naranjo criteria for assessing causal attribution of clinical outcome to homeopathic intervention as presented in case reports
    CD Lamba, VK Gupta, R Van Haselen, L Rutten, N Mahajan, AM Molla, ...
    Homeopathy 109 (04), 191-197 , 2020
    2020
    Citations: 278
  • Interim management of COVID-19 by repurposed homeopathic medicines
    N Basu, BC Das, S Tandon
    Homeopathy 109 (03), 182-183 , 2020
    2020
    Citations: 18
  • Calendula mother tincture vs normal saline for ulcer dressing as an add-on to individualized homoeopathic intervention in the management of diabetic foot ulcer: a randomized …
    H Ponnam, C Lamba, P Oberai, S Masood, S Yandamuri, M Rao, ...
    Indian Journal of Research in Homoeopathy 14 (4), 233-241 , 2020
    2020
    Citations: 10
  • Homoeopathic therapy in cervical spondylosis pain management: A randomised, double-blind, placebo-controlled trial
    J Gupta, R Bawaskar, P Rao, A Shivadikar, P Sumithran, R Pal, S Ali, ...
    Indian Journal of Research in Homoeopathy 14 (4), 242-250 , 2020
    2020
    Citations: 9
  • Optimising the use of polar symptoms in Homoeopathy: Introduction to a pilot study of prognostic factor research in chronic cough
    H Kaur, C Lamba, J Sachdeva, L Rutten, A Khurana, P Oberai, ...
    Indian Journal of Research in Homoeopathy 14 (3), 200-210 , 2020
    2020
    Citations: 5
  • Homoeopathic medicine–Sepia for the management of menopausal symptoms: A multicentric, randomised, double-blind placebo-controlled clinical trial
    J Gupta, K Dimpi, C Lamba, P Gupta, V Shinde, B Wadhwa, A Soren, ...
    Indian Journal of Research in Homoeopathy 13 (4), 219-228 , 2019
    2019
    Citations: 11
  • Idiopathic Trigeminal Neuralgia: A Case Report
    CD Lamba, S Jain
    Homœopathic Links 31 (04), 254-258 , 2018
    2018
    Citations: 1
  • Prognostic factor research on homeopathic cough treatment in India
    L Rutten, CD Lamba, H Kaur
    Homeopathy 107 (S 01), A024 , 2018
    2018
    Citations: 1
  • Individualized Homoeopathic Intervention (IHI) in Diabetic Foot Ulcer (DFU): A Randomized Controlled Pilot Study (RCPS) using Calendula Q vs. Normal Saline (NS) for Ulcer Dressing
    HB Ponnam, RK Manchanda, CD Lamba, P Oberai
    Homeopathy 107 (S 01), P020 , 2018
    2018
    Citations: 1
  • Evaluation of homoeopathic treatment in polycystic ovary syndrome: a single-blind, randomised, placebo-controlled pilot study
    C Lamba, P Oberai, R Manchanda, P Rath, P Bindu, M Padmanabhan
    Indian Journal of Research in Homoeopathy 12 (1), 35-45 , 2018
    2018
    Citations: 41

MOST CITED SCHOLAR PUBLICATIONS

  • Evaluation of the modified Naranjo criteria for assessing causal attribution of clinical outcome to homeopathic intervention as presented in case reports
    CD Lamba, VK Gupta, R Van Haselen, L Rutten, N Mahajan, AM Molla, ...
    Homeopathy 109 (04), 191-197 , 2020
    2020.0
    Citations: 278
  • Effect of individualized homoeopathic treatment in influenza like illness: A multicenter, single blind, randomized, placebo controlled study
    CN PS Chakraborty, CD Lamba, D Nayak, MD John, DB Sarkar, Amitava Poddar, JS ...
    IJRH 7 (1), 22-30 , 2013
    2013.0
    Citations: 46
  • Evaluation of homoeopathic treatment in polycystic ovary syndrome: a single-blind, randomised, placebo-controlled pilot study
    C Lamba, P Oberai, R Manchanda, P Rath, P Bindu, M Padmanabhan
    Indian Journal of Research in Homoeopathy 12 (1), 35-45 , 2018
    2018.0
    Citations: 41
  • Case reporting in homeopathy—an overview of guidelines and scientific tools
    M Teut, RA van Haselen, L Rutten, CD Lamba, G Bleul, S Ulbrich-Zürni
    Homeopathy 111 (01), 002-009 , 2022
    2022.0
    Citations: 40
  • Management of distress during climacteric years by homeopathic therapy
    C Nayak, V Singh, K Singh, H Singh, J Gupta, CD Lamba, A Sharma, ...
    The Journal of Alternative and Complementary Medicine: Paradigm, Practice … , 2011
    2011.0
    Citations: 37
  • Interim management of COVID-19 by repurposed homeopathic medicines
    N Basu, BC Das, S Tandon
    Homeopathy 109 (03), 182-183 , 2020
    2020.0
    Citations: 18
  • Homoeopathic medicine–Sepia for the management of menopausal symptoms: A multicentric, randomised, double-blind placebo-controlled clinical trial
    J Gupta, K Dimpi, C Lamba, P Gupta, V Shinde, B Wadhwa, A Soren, ...
    Indian Journal of Research in Homoeopathy 13 (4), 219-228 , 2019
    2019.0
    Citations: 11
  • Calendula mother tincture vs normal saline for ulcer dressing as an add-on to individualized homoeopathic intervention in the management of diabetic foot ulcer: a randomized …
    H Ponnam, C Lamba, P Oberai, S Masood, S Yandamuri, M Rao, ...
    Indian Journal of Research in Homoeopathy 14 (4), 233-241 , 2020
    2020.0
    Citations: 10
  • Homoeopathic therapy in cervical spondylosis pain management: A randomised, double-blind, placebo-controlled trial
    J Gupta, R Bawaskar, P Rao, A Shivadikar, P Sumithran, R Pal, S Ali, ...
    Indian Journal of Research in Homoeopathy 14 (4), 242-250 , 2020
    2020.0
    Citations: 9
  • How to assess variation in homeopathic prognostic factor research?
    L Rutten, JE Eizayaga, H Kaur, S Rao, A Bajpai, CD Lamba, J Sachdeva, ...
    Homeopathy 115 (01), 033-045 , 2026
    2026.0
    Citations: 7
  • MONARCH inventory for causal attribution in homeopathy case reports: Explanation and elaboration
    CD Lamba, N Mahajan, VK Gupta, L Rutten, M Teut, L Tapakis, T Hoover, ...
    Homeopathy 114 (03), 173-182 , 2025
    2025.0
    Citations: 7
  • Optimising the use of polar symptoms in Homoeopathy: Introduction to a pilot study of prognostic factor research in chronic cough
    H Kaur, C Lamba, J Sachdeva, L Rutten, A Khurana, P Oberai, ...
    Indian Journal of Research in Homoeopathy 14 (3), 200-210 , 2020
    2020.0
    Citations: 5
  • A case of radiation-induced mucositis
    R Shaji Kumar, J Sachdeva, C Lamba
    Indian Journal of Research in Homoeopathy 11 (4), 257-261 , 2017
    2017.0
    Citations: 5
  • Evaluation of the modified naranjo criteria for assessing causal attribution of clinical outcome to homeopathic intervention as presented in case reports. Homeopathy. Tanuja BM …
    CD Lamba, VK Gupta, RV Haselen, L Rutten, N Mahajan, AM Molla
    Cited Here , 0
    Citations: 5
  • Counting polar symptoms: how to represent results?
    L Rutten, J Eizayaga, H Kaur, CD Lamba, J Sachdeva, A Khurana, ...
    Homeopathy 110 (01), 027-035 , 2021
    2021.0
    Citations: 4
  • Erratum: Evaluation of the Modified Naranjo criteria for assessing causal attribution of clinical outcome to homeopathic intervention as presented in case reports
    CD Lamba, VK Gupta, R van Haselen, L Rutten, N Mahajan, AM Molla, ...
    Homeopathy 109 (04), e1-e2 , 2020
    2020.0
    Citations: 4
  • Homoeopathic treatment for chronic cough–a multicentric, prospective, exploratory trial
    H Kaur, L Rutten, S Rao, A Bajpai, CD Lamba, J Sachdeva, V ER, ...
    International Journal of High Dilution Research-ISSN 1982-6206 23 (cf), 146-160 , 2024
    2024.0
    Citations: 3
  • Tylophora indica - A Multicentric Clinical Verification Study
    Indian J Res Homoeopathy 4 (No.4.), 12-18 , 2010
    2010.0
    Citations: 3
  • Enhancing Homeopathic Prescribing for Chronic Cough by Classifying the Reliability of Polar Symptoms
    H Kaur, L Rutten, JE Eizayaga, S Rao, A Bajpai, CD Lamba, J Sachdeva, ...
    Homeopathy , 2025
    2025.0
    Citations: 2
  • A randomised comparative study to evaluate the efficacy of homoeopathic treatment-vs-standard allopathy treatment for acute adenolymphangitis due to lymphatic filariasis
    J Gupta, R Manchanda, L Debata, G Payal, S Choudhary, A Prusty, ...
    Indian Journal of Research in Homoeopathy 12 (2), 64-74 , 2018
    2018.0
    Citations: 2